Dimenhydrinate

2 trials AGastroenterology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

3 Sponsors

17 Countries

Phase III

Other

Phase III: 1 Other: 1

Oversight events:

1 unexpected event across 1 trial

View oversight register →

Indications tested

Motion sickness 1 Relapsing-remitting multiple sclerosis 1 Prophylaxis against motion sickness 1

Sponsors using this IMP

CCDRD Cooperative Clinical Drug Research and Development AG 1 F. Hoffmann-La Roche AG 1 Hermes Pharma GmbH 1

All trials

2 total

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison with Fingolimod in Children and Adolescents with Relapsing-Remitting Mu… Ended

2023-506516-40-00 Phase III 17 countries F. Hoffmann-La Roche AG
An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavaila… Ended

2022-502420-51-00 1 country CCDRD Cooperative Clinical Drug Research and Development AG; Hermes Pharma GmbH

Showing 1–2 of 2 trials

← All drugs A–Z